C9141 HCPCS Level II code: Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
CMS terminated C9141: its last date of service was Jun 30, 2019. It stays here for looking up older claims; newer services need a current code.
Official description
C9141Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
Short description: Factor viii pegylated-aucl
HCPCS · United States
Medicare details
The indicators CMS publishes with C9141 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Added
- Apr 1, 2019
- Terminated after
- Jun 30, 2019
Where C9141 sits
- 1C codesOutpatient prospective payment system
- 2Terminated C9141Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code C9141 still valid?
No. CMS terminated C9141; its last date of service was Jun 30, 2019. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover C9141?
CMS lists C9141’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9141
All C codesC9135Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.C9136Injection, factor viii, fc fusion protein, (recombinant), per i.u.C9137Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.C9138Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.C9139Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.C9140Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.C9142Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mgC9143Cocaine hydrochloride nasal solution (numbrino), 1 mgC9144Injection, bupivacaine (posimir), 1 mgC9145Injection, aprepitant, (aponvie), 1 mgC9146Injection, mirvetuximab soravtansine-gynx, 1 mgC9147Injection, tremelimumab-actl, 1 mg